Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

FORMULATION ASPECTS OF EZETIMIBE LYOPHILIZED DRY EMULSION TABLETS

  Authors

  Kartik Sharad Sonej,  Miss. Dipika Hiraman Gosavi,  Vaibhav Machhindra Sawant,  Dhiraj Anil Pawar,  Prasad Shavan Surse

  Keywords

Ezetimibe, lyophilized dry emulsion tablet, and hyperlipidemia, freeze drying, Labrafac

  Abstract


Ezetimibe is the first lipid-lowering drug that inhibits the intestinal absorption of dietary and biliary cholesterol without affecting the absorption of fat-soluble nutrients. After oral administration, ezetimibe is rapidly absorbed and extensively metabolized (>80%) to the pharmacologically active ezetimibe-glucuronide. Total ezetimibe (the sum of 'parent' ezetimibe plus ezetimibe-glucuronide) concentrations reach a maximum 1-2 hours after administration, followed by enterohepatic recycling and gradual elimination. The terminal half-life of ezetimibe and ezetimibe-glucuronide is approximately 22 hours. Consistent with the elimination half-life of ezetimibe, approximately 2-fold accumulation is observed after once-daily dosing. The recommended dose of ezetimibe 10 mg/day can be given in the morning or evening without regard to food.

  IJCRT's Publication Details

  Unique Identification Number - IJCRT2301393

  Paper ID - 230112

  Page Number(s) - d98-d102

  Pubished in - Volume 11 | Issue 1 | January 2023

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Kartik Sharad Sonej,  Miss. Dipika Hiraman Gosavi,  Vaibhav Machhindra Sawant,  Dhiraj Anil Pawar,  Prasad Shavan Surse,   "FORMULATION ASPECTS OF EZETIMIBE LYOPHILIZED DRY EMULSION TABLETS", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.11, Issue 1, pp.d98-d102, January 2023, Available at :http://www.ijcrt.org/papers/IJCRT2301393.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper April 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer